MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with M

Maralixibat

Maralixibat chloride 10mg tablets

No stability information

Stability notes for Maralixibat chloride 10mg tablets

There are no stability notes for this medicine.

Supplier

Livmarli 10mg tablets (Mirum Pharmaceuticals International BV)

Maralixibat chloride 15mg tablets

No stability information

Stability notes for Maralixibat chloride 15mg tablets

There are no stability notes for this medicine.

Supplier

Livmarli 15mg tablets (Mirum Pharmaceuticals International BV)

Maralixibat chloride 20mg tablets

No stability information

Stability notes for Maralixibat chloride 20mg tablets

There are no stability notes for this medicine.

Supplier

Livmarli 20mg tablets (Mirum Pharmaceuticals International BV)

Maralixibat chloride 30mg tablets

No stability information

Stability notes for Maralixibat chloride 30mg tablets

There are no stability notes for this medicine.

Supplier

Livmarli 30mg tablets (Mirum Pharmaceuticals International BV)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.